TCMD · Tactile Systems Technology Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-11 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 4,631 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 11, 2026 with sale prices ranging from $23.89 to $25.42 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
4,631 |
| 2026-05-06 | King Laura G. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | Washington Boyd Vindell |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | Pearson Andrea |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | Huggenberger Raymond |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | Asbury Valerie L. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | Shafer David Brent |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | Volkart Carmen B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-05-06 | BURKE WILLIAM W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
6,521 |
| 2026-03-09 | Pearson Andrea |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-09 | Pearson Andrea |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units that will vest in full on the date of the Company's 2026 annual meeting of stockholders. |
Common Stock
|
852 |
| 2026-02-24 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 6,246 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
6,246 |
| 2026-02-24 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 7,701 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
7,701 |
| 2026-02-24 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 10,993 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
10,993 |
| 2026-02-23 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 14,703 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
14,703 |
| 2026-02-23 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 160 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
160 |
| 2026-02-23 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 4,279 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
4,279 |
| 2026-02-23 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 537 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
537 |
| 2026-02-23 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 5,322 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
5,322 |
| 2026-02-23 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 196 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
196 |
| 2026-02-20 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Award↑
Filing footnotes — Common Stock (Direct)
On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 7,123 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year. |
Common Stock
|
7,123 |
| 2026-02-20 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 15,575 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year. |
Common Stock
|
15,575 |
| 2026-02-20 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 28,216 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year. |
Common Stock
|
28,216 |
| 2026-02-20 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Award↑
Filing footnotes — Common Stock (Direct)
On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 4,058 PSUs. Those earned PSUs vested on February 20, 2026. |
Common Stock
|
4,058 |
| 2026-02-20 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 6,765 PSUs. Those earned PSUs vested on February 20, 2026. |
Common Stock
|
6,765 |
| 2026-02-20 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 19,751 PSUs. Those earned PSUs vested on February 20, 2026. |
Common Stock
|
19,751 |
| 2026-02-20 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,579 PSUs. Those earned PSUs vested on February 20, 2026. |
Common Stock
|
3,579 |
| 2026-02-20 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Award↑
Filing footnotes — Common Stock (Direct)
On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,490 PSUs. Those earned PSUs vested on February 20, 2026. |
Common Stock
|
3,490 |
| 2026-02-19 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. |
Common Stock
|
48,672 |
| 2026-02-19 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. |
Common Stock
|
23,008 |
| 2026-02-19 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date. |
Common Stock
|
6,194 |
| 2026-01-02 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
Adoption date of referenced 10b5-1(c) plan is: 9/11/2025. |
Common Stock
|
5,139 |
| 2025-08-08 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of restricted stock units. |
Common Stock
|
7,762 |
| 2025-05-12 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 Consists of shares sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 2,921 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 12, 2025 with sale prices ranging from $9.935 to $9.945 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
2,921 |
| 2025-05-08 | BURKE WILLIAM W |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Adoption date of referenced 10b5-1(c) plan is: 05-28-2024 Consists of shares sold to cover taxes associated with the settlement of stock units. |
Common Stock
|
3,300 |
| 2025-05-08 | Dodd Sheri Louise |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover taxes associated with the settlement of restricted stock units. |
Common Stock
|
3,149 |
| 2025-05-07 | Shafer David Brent |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-05-07 | Huggenberger Raymond |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-05-07 | Washington Boyd Vindell |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-05-07 | BURKE WILLIAM W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-05-07 | Asbury Valerie L. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-05-07 | King Laura G. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-05-07 | Volkart Carmen B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Common Stock
|
16,078 |
| 2025-03-11 | REUVERS DANIEL L. |
President and CEO |
Gift↑
|
Common Stock
(I)
|
68,162 |
| 2025-03-11 | REUVERS DANIEL L. |
President and CEO |
Gift↓
|
Common Stock
|
68,162 |
| 2025-02-25 | REUVERS DANIEL L. |
President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 Consists of shares sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 28,338 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.09 to $14.49 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
28,338 |
| 2025-02-25 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
Consists of shares sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 6,468 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.40 to $14.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
6,468 |
| 2025-02-25 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 Consists of shares sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 2,066 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.50 to $14.52 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
2,066 |
| 2025-02-24 | Birkemeyer Elaine M. |
CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
Adoption date of referenced 10b5-1(c) plan is: 06-10-2024 Consists of shares sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 3,778 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.70 to $14.715 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
3,778 |
| 2025-02-24 | Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Sell↓
Filing footnotes — Common Stock (Direct)
Consists of shares sold to cover taxes associated with the settlement of stock units. Reflects the weighted average price of 4,830 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.4301 to $14.82 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
4,830 |